Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanjing Elsa Biotechnology is a specialized life sciences company providing high-quality medical intermediates, active pharmaceutical ingredients (APIs), and bulk stock chemicals to the global pharmaceutical and biotechnology industries. Based in Nanjing, China, the company maintains professional research and service teams focused on custom synthesis, particularly in the areas of chiral and heterocyclic chemistry. ELSA Biotechnology supports drug discovery and development programs by supplying key building blocks and offering specialized chemical manufacturing services tailored to the needs of pharmaceutical R&D. The company's product catalog includes a wide range of precursors used in the synthesis of drugs such as dipeptidyl peptidase 4 inhibitors and various anti-infective agents. By maintaining rigorous quality control and technical support, ELSA Biotechnology facilitates the acceleration of early-stage research through to large-scale production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ELSA Biotechnology.